🔍

ONELIFECAP - Onelife Capital

📊 NSE: ONELIFECAP 🏢 Finance & Investments 📅 Last Updated: 12/14/2025 10:42

📢 Recent Corporate Announcements

Onelife Capital Advisors Confirms Non-Applicability of SEBI Large Corporate Framework

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 16 Apr 2026, 06:23 PM

Onelife Capital Advisors Limited has officially informed the stock exchanges that it does not fall under the 'Large Corporate' category as defined by SEBI circular SEBI/HO/DDHS/CIR/P/2018/144. This classification relates to the mandatory requirement for large entities to raise a portion of their incremental borrowings through debt securities. As the company does not meet the criteria, it is exempt from these specific debt-raising mandates for the current period. This is a routine compliance disclosure typically filed at the end of a financial cycle.

Company confirms it does not meet the criteria for 'Large Corporate' (LC) status under SEBI guidelines.
Exempt from mandatory fund-raising of 25% of incremental borrowings through debt securities.
Disclosure filed in compliance with SEBI circular dated November 26, 2018.
No impact on the company's current financial standing or operational capabilities.

💡 This is a routine regulatory filing with no impact on the company's valuation or business model. No action is required from investors based on this specific announcement.

Onelife Capital Board Approves Loans and Investments Totaling ₹14 Crore

🔵 WATCH ⭐ 6/10

BOARD_MEETING 📅 27 Mar 2026, 04:14 PM

Onelife Capital Advisors has approved the deployment of ₹14 crore through various loans and a subsidiary investment. The board sanctioned a ₹5.50 crore loan to Abhidev Consultancy Services at a 12% interest rate and a ₹1.50 crore loan to an individual, Mr. JayKishor Chatuvedi. Furthermore, credit facilities totaling ₹5.50 crore were approved for two NBFCs, alongside a ₹1.50 crore investment in its subsidiary, Dealmoney Real Estate. This move indicates an active capital allocation strategy, though the risk profile of these private loans warrants scrutiny.

Approved a loan of ₹5.50 crore to Abhidev Consultancy Services Private Limited at 12% interest per annum.
Authorized loans totaling ₹3.50 crore to Gandhi Nagar Leasing and Finance Limited and ₹2.00 crore to Jeevan Jyoti Vanijya Limited.
Granted a personal loan of ₹1.50 crore to Mr. JayKishor Chatuvedi on board-decided terms.
Sanctioned an investment of up to ₹1.50 crore in subsidiary Dealmoney Real Estate Private Limited.
Total capital deployment across all approved items amounts to ₹14 crore.

💡 Investors should monitor the company's ability to recover these loans and the impact on its liquidity position. It is important to evaluate the relationship between the company and the borrowers to ensure there are no corporate governance concerns.

Onelife Capital Board Approves Loans and Investments Totaling ₹14 Crore

🔵 WATCH ⭐ 6/10

BOARD_MEETING 📅 27 Mar 2026, 04:11 PM

Onelife Capital Advisors Limited's board has approved several loans and an investment totaling ₹14 crore. The board sanctioned a loan of ₹5.50 crore to Abhidev Consultancy Services at a 12% interest rate and various loans to NBFCs including Jeevan Jyoti Vanijya and Gandhi Nagar Leasing and Finance. Additionally, a loan of ₹1.50 crore was granted to an individual, Mr. JayKishor Chatuvedi. The company also plans to invest ₹1.50 crore into its subsidiary, Dealmoney Real Estate Private Limited.

Approved a ₹5.50 crore loan to Abhidev Consultancy Services at 12% interest per annum.
Sanctioned loans totaling ₹3.50 crore to Gandhi Nagar Leasing and Finance Limited across two tranches.
Authorized a ₹2.00 crore loan to Jeevan Jyoti Vanijya Limited and ₹1.50 crore to Mr. JayKishor Chatuvedi.
Approved an investment of up to ₹1.50 crore in subsidiary Dealmoney Real Estate Private Limited.

💡 Investors should monitor the company's cash flow and the relationship between the company and the loan recipients to ensure these are arm's length transactions.

Onelife Capital Receives Listing Approval for 2.4 Crore Rights Issue Shares

🟡 NEUTRAL ⭐ 7/10

FUNDRAISE 📅 25 Mar 2026, 05:11 PM

Onelife Capital Advisors Limited has received final listing and trading approvals from both BSE and NSE for its recently concluded Rights Issue. A total of 2,40,00,000 equity shares have been admitted to dealings effective from March 25, 2026. These shares were issued at a price of Rs. 15 per share, which includes a face value of Rs. 10 and a premium of Rs. 5. This marks the successful completion of the company's capital-raising exercise and increases the total tradable equity on the exchanges.

Listing and trading approval granted for 2,40,00,000 equity shares issued via Rights Issue
Shares issued at a total price of Rs. 15 per share (Rs. 10 face value + Rs. 5 premium)
Trading on BSE and NSE commenced on March 25, 2026
Distinctive numbers for the newly listed shares are 13360001 to 37360000

💡 Investors should be aware of the increased equity base and potential dilution of EPS following the listing of these new shares. Monitor the stock for increased liquidity and price volatility as the new shares enter the secondary market.

Onelife Capital Allots 2.4 Crore Rights Equity Shares at ₹15 Per Share

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 17 Mar 2026, 08:40 PM

Onelife Capital Advisors Limited has successfully completed the allotment of 2.4 crore equity shares following its rights issue. The shares were issued at a price of ₹15 each, comprising a face value of ₹10 and a premium of ₹5. This capital infusion has significantly increased the company's paid-up equity share capital from ₹13.36 crore to ₹37.36 crore. The allotment was finalized in accordance with the basis of allotment approved by BSE Limited and the registrar, KFin Technologies.

Allotted 2,40,00,000 Rights Equity Shares at an issue price of ₹15 per share
Total paid-up equity capital increased from ₹13.36 crore to ₹37.36 crore
Total number of equity shares outstanding increased from 1,33,60,000 to 3,73,60,000
The issue price included a premium of ₹5 per share over the face value of ₹10
Allotment finalized in consultation with BSE Limited and KFin Technologies Limited

💡 Investors should note the significant equity dilution resulting from the nearly 180% increase in share count. Monitor how the company utilizes the newly raised capital to drive growth and offset the impact on Earnings Per Share (EPS).

Onelife Capital Re-appoints Three Independent Directors for Second 5-Year Terms

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Mar 2026, 07:06 PM

Onelife Capital Advisors Limited has received shareholder approval via postal ballot for the re-appointment of three independent directors for their second five-year terms. Dr. Ranu Jain and Mr. Nitesh Singh have been re-appointed effective from March 29, 2026, while Mr. Abhay Sethia's second term is effective from January 13, 2026. These directors bring significant experience in capital markets, finance, and taxation, with professional backgrounds ranging from 11 to over 15 years. The move ensures continuity in the company's governance and oversight framework.

Re-appointment of Dr. Ranu Jain as Independent Director for a 5-year term starting March 29, 2026.
Re-appointment of Mr. Nitesh Singh as Independent Director for a 5-year term starting March 29, 2026.
Re-appointment of Mr. Abhay Sethia as Independent Director for a 5-year term starting January 13, 2026.
Shareholder approval for all three re-appointments was secured through a Postal Ballot on March 7, 2026.

💡 No immediate action is required as these are routine re-appointments of existing board members. Investors should view this as a sign of management stability and continuity in corporate governance.

Onelife Capital Shareholders Approve Re-appointment of Three Independent Directors

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Mar 2026, 07:03 PM

Onelife Capital Advisors Limited has successfully passed three special resolutions via postal ballot for the re-appointment of its Independent Directors. Dr. Ranu Jain, Mr. Nitesh Singh, and Mr. Abhay Sethia have all been re-appointed for a second five-year term. Each resolution received overwhelming support with approximately 99.82% of votes cast in favor. The voting process saw a 54.83% total turnout, heavily anchored by 100% promoter participation in favor of the appointments.

Re-appointment of three Independent Directors for a second 5-year term approved via special resolution.
All resolutions passed with a high approval rate of 99.82% of the valid votes cast.
Total voter turnout was 54.83%, representing 7,324,631 valid votes out of 13,360,000 shares.
Promoter group provided 100% support for the resolutions with 6,959,999 votes in favor.
Public non-institutional participation was low at approximately 5.7% turnout.

💡 This is a routine governance update ensuring board continuity and regulatory compliance. Investors should focus on the company's upcoming financial performance rather than this administrative milestone.

Onelife Capital Shareholders Approve Re-appointment of Three Independent Directors

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 10 Mar 2026, 06:58 PM

Onelife Capital Advisors Limited has announced the successful passage of three special resolutions via postal ballot, ensuring board continuity. Shareholders approved the re-appointment of Dr. Ranu Jain, Mr. Nitesh Singh, and Mr. Abhay Sethia as Non-Executive Independent Directors for their second five-year terms. Each resolution received overwhelming support, with approximately 99.82% of the total votes cast in favor. The promoter group, holding 6,959,999 shares, voted entirely in favor of all three appointments.

Re-appointment of Dr. Ranu Jain, Mr. Nitesh Singh, and Mr. Abhay Sethia for a second 5-year term each.
All three special resolutions passed with a high majority of approximately 99.82% in favor.
A total of 7,324,631 valid votes were cast during the remote e-voting process ending March 7, 2026.
Promoter group participation was 100% in favor, contributing 6,959,999 votes to each resolution.
Public non-institutional shareholders cast 364,632 votes, with over 96% supporting the re-appointments.

💡 No immediate action is required as these re-appointments represent routine management continuity. Investors should view the high approval ratings as a sign of stable corporate governance.

Onelife Capital Extends Rights Issue Closing Date to March 16, 2026

🟡 NEUTRAL ⭐ 6/10

FUNDRAISE 📅 02 Mar 2026, 04:15 PM

Onelife Capital Advisors Limited has announced an extension for its ongoing Rights Issue, which originally opened on February 23, 2026. The closing date has been moved from March 06, 2026, to March 16, 2026, to allow more time for shareholders to participate. Additionally, the last date for on-market renunciation of rights entitlements has been extended from March 02, 2026, to March 10, 2026. All other terms and conditions of the Letter of Offer remain unchanged.

Rights Issue closing date extended from March 06, 2026, to March 16, 2026
On-market renunciation deadline extended from March 02, 2026, to March 10, 2026
The issue originally opened on February 23, 2026
No changes made to the terms and conditions of the Letter of Offer (LOF)

💡 Eligible shareholders who haven't yet applied or renounced their rights now have until March 16 and March 10 respectively. Investors should evaluate the rights offer based on the company's fundamentals before the new deadline.

Onelife Capital to Raise ₹36 Crore via Rights Issue; Sets Record Date for Feb 16, 2026

🔵 WATCH ⭐ 8/10

FUNDRAISE 📅 10 Feb 2026, 04:57 PM

Onelife Capital Advisors Limited has finalized the details for a ₹36 crore Rights Issue, offering 2.4 crore equity shares at ₹15 per share. The company has set February 16, 2026, as the record date to determine eligible shareholders. The entitlement ratio is fixed at 300 shares for every 167 shares held, which will significantly expand the equity base from 1.33 crore to 3.73 crore shares. The subscription window is scheduled to open on February 23 and close on March 6, 2026.

Total issue size of ₹36 crore through 2,40,00,000 equity shares at ₹15 per share.
Rights Entitlement Ratio of 300:167 for shareholders as of the Feb 16, 2026 record date.
Post-issue equity capital will increase by approximately 180% to 3.73 crore shares.
Rights Issue period is set from February 23, 2026, to March 6, 2026.
On-market renunciation period ends on March 2, 2026.

💡 Investors should evaluate the significant dilution of nearly 180% against the company's intended use of the ₹36 crore capital. Shareholders must decide to subscribe, sell, or renounce their rights before the March 2nd deadline to prevent value loss.

Onelife Capital Advisors Announces ₹36 Crore Rights Issue at ₹15 Per Share

🔵 WATCH ⭐ 8/10

FUNDRAISE 📅 10 Feb 2026, 04:11 PM

Onelife Capital Advisors has approved a rights issue to raise up to ₹36 crore by issuing 2.4 crore equity shares. The issue price is set at ₹15 per share, which includes a premium of ₹5 over the face value. Eligible shareholders as of the record date, February 16, 2026, can subscribe in a ratio of 300 shares for every 167 shares held. The issue will be open for subscription from February 23 to March 06, 2026.

Total issue size of ₹36.00 crore through the issuance of 2,40,00,000 equity shares
Rights entitlement ratio fixed at 300:167, leading to significant equity dilution
Issue price of ₹15 per share represents a ₹5 premium over the ₹10 face value
Total outstanding shares to increase from 1,33,60,000 to 3,73,60,000 post-issue
Record date for eligibility is February 16, 2026, with the issue closing on March 06, 2026

💡 Investors should evaluate the issue price of ₹15 against the current market price to decide whether to subscribe or renounce their rights. Be aware that the nearly 180% increase in share capital will lead to substantial earnings dilution.

Onelife Capital Seeks Re-appointment of 3 Independent Directors for 5-Year Terms

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 05 Feb 2026, 07:45 PM

Onelife Capital Advisors has initiated a postal ballot process to seek shareholder approval for the re-appointment of three Non-executive Independent Directors. The directors, Dr. Ranu Jain, Mr. Nitesh Singh, and Mr. Abhay Sethia, are proposed for a second five-year term each, extending their tenures into 2031. Shareholders as of the January 30, 2026 cut-off date are eligible to participate in the remote e-voting process. The voting window is scheduled to remain open from February 6, 2026, to March 7, 2026.

Proposed re-appointment of Dr. Ranu Jain and Mr. Nitesh Singh for 5-year terms from March 2026 to March 2031
Proposed re-appointment of Mr. Abhay Sethia for a 5-year term from January 2026 to January 2031
Remote e-voting period set from February 6, 2026, to March 7, 2026
Cut-off date for shareholder eligibility was January 30, 2026
All three re-appointments require approval via Special Resolutions through postal ballot

💡 Investors should review the directors' backgrounds and cast their votes through the CDSL e-voting platform before the March 7 deadline. This is a routine governance matter intended to maintain board stability and regulatory compliance.

Onelife Capital Appoints Satish Kumar as CFO and Finalizes Q3 FY26 Results

🔵 WATCH ⭐ 7/10

MANAGEMENT 📅 03 Feb 2026, 07:57 PM

Onelife Capital Advisors has appointed Mr. Satish Kumar as the permanent Chief Financial Officer effective February 3, 2026, following the resignation of the interim CFO. The company reported its Q3 FY26 financial results, where auditors highlighted a significant investment of ₹10,291.67 lacs in subsidiaries, some of which have negative net worth. Additionally, the board has re-appointed two independent directors for five-year terms and is moving forward with a Postal Ballot for shareholder approvals. Modalities for a previously proposed Rights Issue, including pricing and entitlement ratios, remain under deliberation by a specific committee.

Appointment of Mr. Satish Kumar as CFO with over 10 years of finance experience.
Auditor's emphasis on ₹10,291.67 lacs invested in subsidiaries with negative net worth.
Outstanding GST liability of ₹39.60 Lakhs identified, with ₹13.80 Lakhs recently paid.
Re-appointment of Independent Directors Nitesh Singh and Dr. Ranu Jain for 5-year terms starting March 2026.
Rights Issue modalities including price and record date to be finalized in an upcoming committee meeting.

💡 Investors should closely monitor the upcoming Rights Issue pricing and the auditor's concerns regarding the recoverability of investments in subsidiaries. The transition to a permanent CFO is positive, but the financial health of underlying subsidiaries remains a key risk factor.

Onelife Capital Appoints New CFO, Re-appoints Directors, and Reports Q3 FY26 Results

🔵 WATCH ⭐ 6/10

MANAGEMENT 📅 03 Feb 2026, 07:53 PM

Onelife Capital Advisors has appointed Mr. Satish Kumar as the new CFO following the resignation of interim CFO Mr. Pandoo Naig. The board also approved the re-appointment of two Independent Directors for five-year terms and cleared the Q3 FY26 financial results. A significant auditor note highlights investments of ₹10,291.67 lakhs in subsidiaries, some of which have negative net worth, though no impairment has been recognized yet. The company is also moving forward with a Rights Issue, with pricing and ratios to be finalized by a separate committee.

Mr. Satish Kumar appointed as Chief Financial Officer effective February 3, 2026.
Auditor flagged ₹10,291.67 lakhs investment in subsidiaries with negative net worth.
Re-appointment of Independent Directors Nitesh Singh and Dr. Ranu Jain for 5-year terms.
Company holds a 24.56% stake in Continental Controls Limited as an associate company.
Rights Issue details including price and entitlement ratio deferred to a specific committee.

💡 Investors should exercise caution and monitor the performance of subsidiaries where ₹102.9 crore is invested, as future impairments could impact the bottom line. Stay tuned for the Rights Issue Committee's announcement regarding the pricing and record date.

Onelife Capital Q3 Results, New CFO Appointment, and Rights Issue Update

🔵 WATCH ⭐ 7/10

BOARD_MEETING 📅 03 Feb 2026, 07:45 PM

Onelife Capital Advisors approved its Q3 FY26 financial results and announced the appointment of Mr. Satish Kumar as the new CFO following the resignation of Mr. Pandoo Naig. The board also approved the re-appointment of two independent directors for a five-year term. Notably, the company is progressing with a Rights Issue, though specific pricing and ratios have been deferred to a dedicated committee. Investors should note the auditor's emphasis on ₹10,291.67 lakhs invested in subsidiaries with negative net worth.

Approved Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025.
Appointed Mr. Satish Kumar as CFO effective February 3, 2026, following the resignation of Mr. Pandoo Naig.
Auditor's report highlighted ₹10,291.67 lakhs invested in subsidiaries, some of which have negative net worth.
Rights Issue modalities including price and entitlement ratio deferred to the Rights Issue Committee.
Identified an outstanding GST liability of ₹39.60 lakhs from previous years, with ₹13.80 lakhs recently paid.

💡 Investors should closely monitor the upcoming pricing and ratio details of the Rights Issue and the recoverability of the ₹102.9 crore investment in subsidiaries. The auditor's emphasis of matter regarding subsidiary net worth and tax liabilities suggests a cautious outlook.

View All ONELIFECAP Announcements on Live Market Tracking →

💰 Financial Performance

Geographic Revenue Split

100% of revenue is derived from India, with the registered office located in Thane, Maharashtra.

Profitability Margins

Not disclosed in available documents; however, the company notes Emphasis of Matters in audits regarding management judgment and reliance on future performance of subsidiaries.

Capital Expenditure

Planned capital raising of up to INR 30 Crores through a Rights Issue of equity shares with a face value of INR 10 each, approved on December 10, 2025.

Credit Rating & Borrowing

Not disclosed in available documents; however, the company plans to use Rights Issue proceeds to adjust loans availed from the Promoter Group.

⚙️ Operational Drivers

Raw Materials

Not applicable for a financial advisory and technology firm; primary inputs are human capital and proprietary technology infrastructure.

Capacity Expansion

The company operates 8 subsidiaries across diversified segments including Financial Services, Healthcare, and E-commerce. Expansion is focused on scaling the margin funding capacity of its subsidiary, Dealmoney Commodities Private Limited (DCPL), via a proposed INR 30 Crores infusion.

📈 Strategic Growth

Growth Strategy

OCAL plans to achieve growth by raising up to INR 30 Crores through a Rights Issue to fund the working capital and margin funding requirements of its subsidiary, DCPL. Additionally, the company is integrating its 8 subsidiaries into the 'Onelifetouch' Super App to capitalize on the Indian e-commerce market, which is projected to surpass US$ 350 billion by 2030.

Products & Services

Capital raising advisory (debt and equity), deal structuring, investment management, 'Ready' proprietary software, 'Onelifetouch' Super App, stock broking, and commodity broking.

Brand Portfolio

Ready (Software), Onelifetouch (Super App), Dealmoney (Group Brand).

New Products/Services

Integration of all 8 high-growth business verticals into the 'Onelifetouch' Super App to provide an integrated business platform.

Market Expansion

Targeting pan-India digital integration through the 'Onelifetouch' platform to capture synergies across Financial Services, Healthcare, and E-commerce.

Strategic Alliances

Strategic investments in Dealmoney Group companies to deliver end-to-end advisory and execution services.

🌍 External Factors

Industry Trends

The Indian e-commerce sector is projected to grow to US$ 350 billion by 2030. The industry is shifting towards digital integration and 'Super Apps' that consolidate multiple services. OCAL is positioning itself as an integrated business platform to capture this growth by linking its 8 diversified subsidiaries through a single digital interface.

Competitive Landscape

Operates in highly regulated and intensely competitive segments like stock broking, commodity trading, and wealth management.

Competitive Moat

The company maintains a moat through its integrated ecosystem of 8 subsidiaries covering Financial Services, Healthcare, and E-commerce, all linked via proprietary 'Ready' software and the 'Onelifetouch' Super App. This integration creates high switching costs for clients who rely on the unified digital platform for diverse business needs, ensuring long-term customer retention.

Macro Economic Sensitivity

Highly sensitive to global inflationary pressures and geopolitical conflicts, which impact Indian capital market volumes and the demand for financial advisory services.

Consumer Behavior

Shift towards digital booking, super-app usage, and integrated financial-technology solutions in the Indian market.

Geopolitical Risks

Global geopolitical conflicts and evolving trade dynamics are cited as risks that could indirectly affect OCAL's advisory business and the performance of its subsidiaries.

⚖️ Regulatory & Governance

Industry Regulations

Compliance with the Companies Act, 2013 for corporate governance and operational standards.

Legal Contingencies

Not disclosed in available documents (excluding SEBI/capital market regulator matters).

⚠️ Risk Analysis

Key Uncertainties

Regulatory non-compliance risks and the potential for significant impairment of investments if the 8 subsidiaries fail to achieve anticipated revenue growth or strategic benefits.

Geographic Concentration Risk

100% of operations are concentrated in India, specifically Maharashtra (Thane).

Third Party Dependencies

High dependency on the operational and financial performance of 8 subsidiaries for group-level revenue generation.

Technology Obsolescence Risk

Risk of rapid technological shifts in the financial services and e-commerce sectors requiring continuous and costly updates to the 'Onelifetouch' app and 'Ready' software.